This new white paper from leading regulatory and compliance consultancy, Maetrics, highlights how the COVID-19 pandemic is affecting the key business function that safe-guards patient safety: regulatory and quality compliance in the life science sector.

Maetrics offers critical insights to an industry under pressure to meet current global healthcare needs, analyzing specific quality and regulatory issues that have arisen since the start of the pandemic, such as greater supply chain scrutiny. It includes a high level discussion of the strategic approach needed to provide effective regulatory and quality support across the entire organization, as well as a comprehensive checklist for RA & QA professionals which can be used to assess internal readiness for existing and upcoming regulatory changes.